Back to Companies
Jasper Therapeutics, Inc.
JSPRNasdaqCIK: 0001788028
Jasper Therapeutics, Inc. (JSPR) shows 13 recent insider filings from 10 insiders, with all of them on the buy side. With $347.5K in purchases and $0 in sales, the recent tape is heavily weighted toward buying (a net purchase of $347.5K). MARTELL RON (President, CEO and Director, Director) is the most active by dollar volume, and the single largest transaction was $430.6K by MARTELL RON. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$1.5M
Purchases
$347.5K
Sales
$0
Unique Insiders
10
Recent Insider Trades
13 loaded
| Jul 22 | JSPR Jasper Therapeutics, Inc. | Ros Matthew E | Chief Operating Officer | Other | $0 |
| Jul 20 | JSPR Jasper Therapeutics, Inc. | Crutcher Patrick J | Director | Other | $0 |
| Jul 20 | JSPR Jasper Therapeutics, Inc. | Crutcher Patrick J | Director | Award | $11.6K |
| Jul 22 | JSPR Jasper Therapeutics, Inc. | Song Wenru | EVP, Head of R&D | Other | $0 |
| Jul 23 | JSPR Jasper Therapeutics, Inc. | Keenan Greg | Chief Medical Officer | Other | $0 |
| Jul 22 | JSPR Jasper Therapeutics, Inc. | Ros Matthew E | Chief Operating Officer | Other | $0 |
| Jan 5 | JSPR Jasper Therapeutics, Inc. | Mahal Jeetinder Singh | Chief Operating Officer | Award | $165.6K |
| Jan 5 | JSPR Jasper Therapeutics, Inc. | MARTELL RON | President, CEO and Director, Director | Award | $430.6K |
| Jan 5 | JSPR Jasper Therapeutics, Inc. | CROSS HERB | Chief Financial Officer | Award | $165.6K |
| Sep 24 | JSPR Jasper Therapeutics, Inc. | Lucas Svetlana | Director | Buy | $48.6K |
| Sep 24 | JSPR Jasper Therapeutics, Inc. | WIGGANS THOMAS G | Director | Buy | $99.6K |
| Sep 24 | JSPR Jasper Therapeutics, Inc. | Shizuru Judith Anne | Director | Buy | $99.6K |
| Sep 24 | JSPR Jasper Therapeutics, Inc. | MARTELL RON | President and CEO, Director | Buy | $99.6K |
13 filings